Thus, various methods of immunotherapy were developed such as ICIs including PD-L1 or CTLA-4, monoclonal antibodies, and adaptive cell therapies aiming to strengthen the immune system in recognizing and obliterating cancer [11]. Here, CTLA4 is linked to cancer.